MD1339Z - Metodă de pronostic al riscului de deces la pacienţi cu sindrom cardiorenal de tip 2 şi insuficienţă cardiacă cu fracţia de ejecţie intermediară şi redusă - Google Patents

Metodă de pronostic al riscului de deces la pacienţi cu sindrom cardiorenal de tip 2 şi insuficienţă cardiacă cu fracţia de ejecţie intermediară şi redusă Download PDF

Info

Publication number
MD1339Z
MD1339Z MDS20180116A MDS20180116A MD1339Z MD 1339 Z MD1339 Z MD 1339Z MD S20180116 A MDS20180116 A MD S20180116A MD S20180116 A MDS20180116 A MD S20180116A MD 1339 Z MD1339 Z MD 1339Z
Authority
MD
Moldova
Prior art keywords
death
cys
risk
heart failure
determined
Prior art date
Application number
MDS20180116A
Other languages
English (en)
Russian (ru)
Inventor
Елена БИВОЛ
Ливий ГРИБ
Константин ЖУКОВСКИЙ
Original Assignee
Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова
Институт Кардиологии Республики Молдова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова, Институт Кардиологии Республики Молдова filed Critical Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова
Priority to MDS20180116A priority Critical patent/MD1339Z/ro
Publication of MD1339Y publication Critical patent/MD1339Y/ro
Publication of MD1339Z publication Critical patent/MD1339Z/ro

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Invenţia se referă la medicină, în special la cardiologie şi nefrologie.Esenţa invenţiei constă în aceea că se efectuează examenul clinic şi paraclinic, unde se determină nivelul cistatinei C serice (CYS) şi nivelul hemoglobinei (HB), se estimează rata filtrării glomerulare utilizând formula simplă în baza cistatinei C (RFG100/cys), se determină severitatea insuficienţei cardiace (IC), se efectuează examenul ecocardiografic cu aprecierea disfuncţiei ventriculului stâng, se determină gradul de mobilitate a pacientului (MOB), durata bolii cardiovasculare (DBCV) şi prezenţa stresului emoţional (STRESS), iar funcţia discriminantă (F) se calculează conform formulei:F= - 0,552 - 0,601 · RFG100/cys - 0,633 · STRESS + 1,921 · MOB + 1,450 · CYS - 0,054 · DBCV - 0,019 · HB + 0,503 · IC;în cazul în care F > 0 se pronosticheaza un risc crescut de deces, iar F < 0 - un risc scăzut de deces.
MDS20180116A 2018-12-06 2018-12-06 Metodă de pronostic al riscului de deces la pacienţi cu sindrom cardiorenal de tip 2 şi insuficienţă cardiacă cu fracţia de ejecţie intermediară şi redusă MD1339Z (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDS20180116A MD1339Z (ro) 2018-12-06 2018-12-06 Metodă de pronostic al riscului de deces la pacienţi cu sindrom cardiorenal de tip 2 şi insuficienţă cardiacă cu fracţia de ejecţie intermediară şi redusă

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDS20180116A MD1339Z (ro) 2018-12-06 2018-12-06 Metodă de pronostic al riscului de deces la pacienţi cu sindrom cardiorenal de tip 2 şi insuficienţă cardiacă cu fracţia de ejecţie intermediară şi redusă

Publications (2)

Publication Number Publication Date
MD1339Y MD1339Y (ro) 2019-06-30
MD1339Z true MD1339Z (ro) 2020-01-31

Family

ID=67069694

Family Applications (1)

Application Number Title Priority Date Filing Date
MDS20180116A MD1339Z (ro) 2018-12-06 2018-12-06 Metodă de pronostic al riscului de deces la pacienţi cu sindrom cardiorenal de tip 2 şi insuficienţă cardiacă cu fracţia de ejecţie intermediară şi redusă

Country Status (1)

Country Link
MD (1) MD1339Z (ro)

Also Published As

Publication number Publication date
MD1339Y (ro) 2019-06-30

Similar Documents

Publication Publication Date Title
Hagan et al. The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease
Hinojosa-Laborde et al. Validation of lower body negative pressure as an experimental model of hemorrhage
Aissaoui et al. Prediction of post-induction hypotension by point-of-care echocardiography: a prospective observational study
Zakhary et al. Predictors of mortality after extracorporeal cardiopulmonary resuscitation
Kemp et al. Insulin resistance and carotid intima-media thickness mediate the association between resting-state heart rate variability and executive function: A path modelling study
Cases et al. Cardiovascular-kidney-metabolic syndrome definition and its role in the prevention, risk staging, and treatment. An opportunity for the Nephrology
Lubas et al. Impact of cardiovascular organ damage on cortical renal perfusion in patients with chronic renal failure
MD1339Z (ro) Metodă de pronostic al riscului de deces la pacienţi cu sindrom cardiorenal de tip 2 şi insuficienţă cardiacă cu fracţia de ejecţie intermediară şi redusă
MD1341Z (ro) Metodă de pronostic al riscului de accidente vasculare la pacienţi cu sindrom cardiorenal de tip 2 şi insuficienţă cardiacă cu fracţia de ejecţie intermediară şi redusă
Tınazlı et al. Hyperuricemia and Fragmented QRS
Al Fattah et al. Delivery Outcome Among Pregnant Women with Hypertension
Landaluce Triska et al. MO325: Renal Glycosuria in Acute Kidney Injury Predicts the Diagnosis of Acute Interstitial Nephritis
Ahmed et al. THE INVERSE RELATIONSHIP OF PULSE PRESSURE TO LDL CHOLESTEROL IN PATIENTS WITH TYPE II DIABETES AND CKM (CARDIO KIDNEY METABOLIC) DISEASE
Boran et al. Idiopathic Costochondritis and Tietze Syndrome: Atypical Chest Pain Syndromes–Recurrence Rates, Treatment Modalities, Seasonality
Bagordo et al. NATRIURETIC RESPONSE TO SALINE LOAD IN PATIENTS WITH PRIMARY ALDOSTERONISM
Wang et al. Cinnamaldehyde attenuates high glucose-induced oxidative stress and endothelial dysfunction as an Nrf2 activator
Aditya et al. Role of pulse pressure in worsening the renal function of patient with hypertension
Chia et al. Evaluating the Effectiveness of a Pragmatic Intervention in Reducing Blood Pressure in Patients with Hypertension
Mallick et al. Value of ST-Segment Depression with T-Wave Inversion in Lateral Leads I, aVL, V4-V6 in Diagnosing the Left Main or Left Main Equivalent Coronary Artery Disease
Mocan et al. Inflammation and oxidative stress biomarkers as predictors of diastolic dysfunction in patients with metabolic syndrome
Milzman et al. 140: IMPROVED EARLY DIAGNOSIS OF TAKO-TSUBO SYNDROME: RATIO OF BNP: TROPONIN I FOR CARIOGENIC SHOCK PTS
Gottsäter et al. [OP. 7C. 03] CHARACTERISTICS OF SUBJECTS AT LOWER END OF CAROTID-FEMORAL PULSE WAVE VELOCITY DISTRIBUTION, WHY ARE THEY HEALTHY?
Yashio et al. 138: PREVALENCE OF TAKOTSUBO CARDIOMYOPATHY IN EMERGENCY DEPARTMENT
Uzawa et al. 139: TETRASTARCH SUPPRESSES VASCULAR PERMEABILITY IN AN ACUTE HEMORRHAGE MOUSE MODEL
Joly et al. Dissecting the INTERMACS Definition of Right Heart Failure: Can We Really Predict Central Venous Pressure?

Legal Events

Date Code Title Description
FG9Y Short term patent issued
KA4Y Short-term patent lapsed due to non-payment of fees (with right of restoration)